Koneksa Announces Partnership with Beacon Biosignals for Clinical Trial in Sleep and Neurologic Disorders Using EEG Biomarkers
Digital Health Global
JUNE 13, 2023
The LEARNS study seeks to generate evidence to extend the Koneksa solution to new digital modalities and diseases,” said John Wagner, MD, PhD, Chief Medical Officer, Koneksa. Beacon’s mobile EEG will join more than a dozen digital health technologies that are already integrated into the Koneksa solution.
88 
Let's personalize your content